Literature DB >> 5544146

In-vitro activity of erythromycin against atypical mycobacteria.

A Molavi, L Weinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5544146     DOI: 10.1093/infdis/123.2.216

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.

Authors:  N Rastogi; V Labrousse
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.

Authors:  P J Guest; M G Britton; H C Grundy; M D Yates
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

4.  Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination.

Authors:  S P Hanley; J Gumb; J T Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

5.  Treatment of septic arthritis due to Mycobacterium kansasii.

Authors:  G Singh
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16

6.  Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals.

Authors:  D M Yajko; P S Nassos; C A Sanders; P C Gonzalez; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  Rapid in vitro metabolic screen for antileprosy compounds.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors:  R J Wallace; J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.